1 / 1

The Asia Pacific Clinical Nutrition market is estimated to be growing at a CAGR of 7.17%,

The Asia Pacific Clinical Nutrition market was worth USD 3,234.7 Million in 2016 and estimated to be growing at a CAGR of 7.17%, to reach USD 4,849.1 Million by 2022.

zainazad
Download Presentation

The Asia Pacific Clinical Nutrition market is estimated to be growing at a CAGR of 7.17%,

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Asia Pacific Clinical Nutrition Market is predicted to reach USD 4849.1 Million by 2023 The Asia Pacific Clinical Nutrition market was worth USD 3,234.7 Million in 2016 and estimated to be growing at a CAGR of 7.17%, to reach USD 4,849.1 Million by 2022. Asia-Pacific clinical nutritional market is mainly driven by increasing awareness for such products among the common people.Vitamins, Amino acids, minerals, carbohydrates and proteins are some of the essential nutrients required in the diet. Various diseases such as diabetes, cancer, GI diseases, kidney and cardiovascular diseases can be treated or controlled with the use of clinical nutritional products. These are available in the form of liquids, powders, tablets, injections, or foods such as yogurt and Probiotics. View Sample https://www.marketdataforecast.com/market-reports/asia-pacific-clinical-nutrition-market-788/request- sample The high birth rate, growing geriatric population, surge in the number of victims of malnutrition getting treatment, high number of premature birth and rising prevalence of lifestyle associated disease, and increasing incidence of cancer and central nervous system diseases are driving the growth of the clinical nutrition market. Lack of awareness regarding home care of clinical nutrition is hindering the market growth. Get More Details https://www.marketdataforecast.com/market-reports/asia-pacific-clinical-nutrition-market-788/ The Asia-Pacific clinical nutrition market is segmented on the basis of product type into oral nutrition, enteral nutrition and parenteral nutrition. Based on therapeutic areas the market is bifurcated into malabsorption, diarrhoea, cancer, food allergies, maldigestion, diabetes, short-bowel syndrome, acute lung injury and acute respiratory distress. Based on ingredients the market is divided into vitamins, minerals, carbohydrates and amino acids. Enteral nutrition is the product type segment with highest share in the market. Based on geography the market is analysed under various regions namely, China, India, Japan, South Korea and Australia. China and India are expected to emerge fast in the forecast period due to rise in population in the following countries. Get Customized Report https://www.marketdataforecast.com/market-reports/asia-pacific-clinical-nutrition-market-788/customize- report Some of the key participants in clinical nutrition products market include Nestle Nutrition, Abbott Laboratories Inc., Gentiva Health Services Inc., Mead Johnson & Company, Kendall, Ajinomoto Co. Inc., Hospira Inc., Hero Nutritionals Inc., Lonza Ltd, Baxter International Inc., B. Braun Melsungen AG, H. J. Heinz Company, American Home Patient Inc., and Fresenius Kabi among others. Contact Info: Name: Mr. Abhishek Shukla Email: abhishek@marketdataforecast.com Organization: MarketDataForecast™ Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India. Phone: +1-888-702-9626

More Related